FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311752786> ?p ?o ?g. }

• W4311752786 abstract "Abstract Background Arterial hypertension is a complex and in most cases multifactorial pathology. Despite the numerous pharmacological treatments available, it is estimated that in Europe only 25%-39% of hypertensive patients achieve adequate blood pressure (BP) control. Renal arteries denervation (RDN) is an additional therapeutic weapon, complementary to Optimal Medical Therapy (OMT) in patients with resistant or refractory primary (or essential) arterial hypertension. In order to improve patients management and select those who are eligible for renal denervation, our Center has established the Interdisciplinary Group for the Treatment of Resistant Arterial Hypertension (G.I.T.I.A.R.), including Cardiologists, Nephrologists, Internists and Geriatricians. Methods From January 2018 to July 2022 the G.I.T.I.A.R. held twelve meetings evaluating 62 patients with resistant or refractory forms of arterial hypertension, contraindications or intolerance to antihypertensive drugs, suspected secondary or pseudoresistant forms (i.e. linked to poor patient compliance, drugs and/or inadequate dosages, concomitant intake of substances with hypertensive effect, incorrect measurements). For each of them, medical therapy was optimized and the need for second level diagnostic tests, multi-specialist follow-up and RDN candidacy were assessed. After three, six, twelve months and then annually following RDN, the patients underwent clinical and multi-specialist evaluation (where deemed appropriate), blood tests monitoring and 24-hour ambulatory blood pressure monitoring (ABPM). Results Of the 62 patients evaluated by the G.I.T.I.A.R., 64.5% (n=40) were male. The mean age at the time of evaluation was 64 years (range 18-87). After the first collegial discussion, 46.8% (n=29) have been declared eligible for RDN, while 53.2% (n=33) of the patients was initially rejected: 39.4% of these (n=13) for suspected or ascertained secondary hypertension, 12.1% (n=4) for the possibility of further optimization of medical therapy, 48.5% (n=16) for the presence of inclusion or exclusion criteria of ongoing studies design. Among the excluded patients, six presented moderate renal artery stenosis on non-invasive imaging: in two patients (33.3%) the stenosis turned out to be hemodynamically significant on angiographic and functional evaluation (Pd/Pa measurement), so renal angioplasty was performed; RDN was performed in the remaining 66.7% (n=4), in which a hemodynamic significance of the stenosis was excluded. Of the subgroup who had optimized medical therapy, one patient (25%) was subsequently referred to RDN for failure of all pharmacological strategies, while 3 of 4 (75%) achieved adequate BP control. Conclusions Resistant arterial hypertension is associated with an increased risk of development and progression of cardiovascular and renal diseases, with a significant impact on mortality and morbidity. Renal denervation has proved to be an effective and safe therapeutic strategy, complementary to OMT, whose selection of the ideal patient actually represents one of the greatest challenges. The integrated multidisciplinary approach improves the management of the hypertensive patient, the individualization of therapy and allows the identification of subjects who may benefit from RDN." @default.
• W4311752786 created "2022-12-28" @default.
• W4311752786 creator A5003725285 @default.
• W4311752786 creator A5003891933 @default.
• W4311752786 creator A5011415855 @default.
• W4311752786 creator A5014177770 @default.
• W4311752786 creator A5014340020 @default.
• W4311752786 creator A5025860644 @default.
• W4311752786 creator A5033862541 @default.
• W4311752786 creator A5035051569 @default.
• W4311752786 creator A5036992867 @default.
• W4311752786 creator A5037367438 @default.
• W4311752786 creator A5055842339 @default.
• W4311752786 creator A5059087290 @default.
• W4311752786 creator A5060984913 @default.
• W4311752786 creator A5061024391 @default.
• W4311752786 creator A5063535800 @default.
• W4311752786 creator A5065087054 @default.
• W4311752786 creator A5076198451 @default.
• W4311752786 date "2022-12-14" @default.
• W4311752786 modified "2023-09-25" @default.
• W4311752786 title "745 INTERDISCIPLINARY EVALUATION IN RESISTANT ARTERIAL HYPERTENSION" @default.
• W4311752786 doi "https://doi.org/10.1093/eurheartjsupp/suac121.101" @default.
• W4311752786 hasPublicationYear "2022" @default.
• W4311752786 type Work @default.
• W4311752786 citedByCount "0" @default.
• W4311752786 crossrefType "journal-article" @default.
• W4311752786 hasAuthorship W4311752786A5003725285 @default.
• W4311752786 hasAuthorship W4311752786A5003891933 @default.
• W4311752786 hasAuthorship W4311752786A5011415855 @default.
• W4311752786 hasAuthorship W4311752786A5014177770 @default.
• W4311752786 hasAuthorship W4311752786A5014340020 @default.
• W4311752786 hasAuthorship W4311752786A5025860644 @default.
• W4311752786 hasAuthorship W4311752786A5033862541 @default.
• W4311752786 hasAuthorship W4311752786A5035051569 @default.
• W4311752786 hasAuthorship W4311752786A5036992867 @default.
• W4311752786 hasAuthorship W4311752786A5037367438 @default.
• W4311752786 hasAuthorship W4311752786A5055842339 @default.
• W4311752786 hasAuthorship W4311752786A5059087290 @default.
• W4311752786 hasAuthorship W4311752786A5060984913 @default.
• W4311752786 hasAuthorship W4311752786A5061024391 @default.
• W4311752786 hasAuthorship W4311752786A5063535800 @default.
• W4311752786 hasAuthorship W4311752786A5065087054 @default.
• W4311752786 hasAuthorship W4311752786A5076198451 @default.
• W4311752786 hasBestOaLocation W43117527861 @default.
• W4311752786 hasConcept C121332964 @default.
• W4311752786 hasConcept C126322002 @default.
• W4311752786 hasConcept C141071460 @default.
• W4311752786 hasConcept C142424586 @default.
• W4311752786 hasConcept C149323552 @default.
• W4311752786 hasConcept C2777581072 @default.
• W4311752786 hasConcept C2779384505 @default.
• W4311752786 hasConcept C3019558611 @default.
• W4311752786 hasConcept C35785553 @default.
• W4311752786 hasConcept C71924100 @default.
• W4311752786 hasConcept C84393581 @default.
• W4311752786 hasConcept C87355193 @default.
• W4311752786 hasConceptScore W4311752786C121332964 @default.
• W4311752786 hasConceptScore W4311752786C126322002 @default.
• W4311752786 hasConceptScore W4311752786C141071460 @default.
• W4311752786 hasConceptScore W4311752786C142424586 @default.
• W4311752786 hasConceptScore W4311752786C149323552 @default.
• W4311752786 hasConceptScore W4311752786C2777581072 @default.
• W4311752786 hasConceptScore W4311752786C2779384505 @default.
• W4311752786 hasConceptScore W4311752786C3019558611 @default.
• W4311752786 hasConceptScore W4311752786C35785553 @default.
• W4311752786 hasConceptScore W4311752786C71924100 @default.
• W4311752786 hasConceptScore W4311752786C84393581 @default.
• W4311752786 hasConceptScore W4311752786C87355193 @default.
• W4311752786 hasIssue "Supplement_K" @default.
• W4311752786 hasLocation W43117527861 @default.
• W4311752786 hasOpenAccess W4311752786 @default.
• W4311752786 hasPrimaryLocation W43117527861 @default.
• W4311752786 hasRelatedWork W2038343828 @default.
• W4311752786 hasRelatedWork W2055813839 @default.
• W4311752786 hasRelatedWork W2120805831 @default.
• W4311752786 hasRelatedWork W2275528683 @default.
• W4311752786 hasRelatedWork W2278154134 @default.
• W4311752786 hasRelatedWork W2504965259 @default.
• W4311752786 hasRelatedWork W2783542742 @default.
• W4311752786 hasRelatedWork W4381149175 @default.
• W4311752786 hasRelatedWork W2150340826 @default.
• W4311752786 hasRelatedWork W2409996166 @default.
• W4311752786 hasVolume "24" @default.
• W4311752786 isParatext "false" @default.
• W4311752786 isRetracted "false" @default.
• W4311752786 workType "article" @default.